- •
The number of children with inflammatory bowel disease (IBD) is on the increase.
- •
Crohn disease and ulcerative colitis, the main subtypes of this intestinal inflammatory disease, affect both children and adults.
- •
Children are developing physically, emotionally, and immunologically. The interface between this development and IBD affects presentation, diagnosis, and management.
- •
This review focuses on the special aspects of pediatric IBD and how these influence management of children with IBD.
Update in Pediatric Inflammatory Bowel Disease
Section snippets
Key points
Pathogenesis
Although the cause is unclear, IBD is believed to result from an interaction of genetics, host immunity, and environmental factors. One of the most important risk factors for developing IBD is a positive family history of the disorder.7 Other possible factors include a child’s living conditions,8, 9 maternal smoking, and older maternal age during pregnancy.10 Controversial factors include the protective role of breast-feeding and whether certain vaccines, in particular measles vaccines, are
Diagnosis
Similar to adults, pediatric patients with IBD present most commonly with diarrhea and abdominal pain (Table 1). Rectal bleeding occurs more often in patients with ulcerative colitis, whereas patients with Crohn disease are more likely to have perianal disease. Weight loss is seen in most children with Crohn disease at the time of presentation. This malnutrition in these patients results from suboptimal dietary intake, increased gastrointestinal losses, malabsorption, and possibly increased
Treatment
The therapeutic goal in treating patients with IBD is mucosal healing and long-lasting remission. Treatment of pediatric patients with IBD should focus on the individual patient and requires a commonsense approach, with consideration of symptoms and quality of life, including growth, and minimizing side effects. There is a paucity of therapies approved specifically for children with IBD, therefore most of the treatment regimens are extrapolated from adult studies. Similar to adults with IBD,
Summary
The incidence of IBD in children is on the increase and approximately one-quarter of patients with IBD present in childhood. Pediatric patients with IBD can suffer both physically and psychosocially. An individualized therapeutic strategy in a child with IBD is necessary in terms of both medical and psychosocial management. Special attention should be paid to growth, immunizations, and mental health. IBD is a disorder with potential morbidities and lifelong challenges, therefore understanding
References (59)
- et al.
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study
J Pediatr
(2003) - et al.
Inflammatory bowel disease in pediatric and adolescent patients
Gastroenterol Clin North Am
(1999) - et al.
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry
J Pediatr
(2005) - et al.
Sex-specific risks for pediatric onset among patients with Crohn’s disease
Clin Gastroenterol Hepatol
(2003) - et al.
Inflammatory bowel disease in spouses and their offspring
Gastroenterology
(2001) - et al.
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics
Gastroenterology
(2003) - et al.
The genetics of inflammatory bowel disease
Gastroenterology
(2003) - et al.
Genetics in diagnosing and managing inflammatory bowel disease
Gastroenterol Clin North Am
(2012) - et al.
Decreased height velocity in children and adolescents before the diagnosis of Crohn’s disease
Gastroenterology
(1988) - et al.
Relationship of type I procollagen to corticosteroid therapy in children with inflammatory bowel disease
J Pediatr
(1988)
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Gastroenterology
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
Gastroenterology
Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease
Am J Gastroenterol
Increased immune reactivity predict aggressive complicating Crohn’s disease in children
Clin Gastroenterol Hepatol
Focally enhanced gastritis in children with Crohn’s disease and ulcerative colitis
Am J Gastroenterol
Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial
Clin Gastroenterol Hepatol
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn’s disease
Gastroenterology
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
Gastroenterology
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response
Gastroenterology
One year data from the Sonic Study: a randomized, double-blind trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy
Gastroenterology
Vitamin D status in children, adolescents, and young adults with Crohn disease
Am J Clin Nutr
Inflammatory bowel disease and the risk of fracture
Gastroenterology
Osteoporosis and measurement of bone mass in children and adolescents
Endocrinol Metab Clin North Am
Special issues in pediatric inflammatory bowel disease
World J Gastroenterol
Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001
Gut
A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease
Scand J Gastroenterol
The genetics of inflammatory bowel disease
Aliment Pharmacol Ther
A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease
Eur J Gastroenterol Hepatol
Small-area variations and sociodemographic correlates for the incidence of Crohn’s disease and ulcerative colitis
Am J Epidemiol
Cited by (26)
Hirschsprung-associated inflammatory bowel disease: A multicenter study from the APSA Hirschsprung disease interest group
2023, Journal of Pediatric SurgeryInflammatory bowel disease. Ulcerative colitis
2020, Medicine (Spain)Impaired objective and subjective sleep in children and adolescents with inflammatory bowel disease compared to healthy controls
2017, Sleep MedicineCitation Excerpt :The underlying causes of IBD have not been fully identified; however, current theories acknowledge interactions between the intestinal gut microflora and the mucosa, especially in predisposed hosts, as responsible underlying mechanisms. Genetic factors seem to contribute only partially, while there is growing recognition that the microbial and environmental dimensions play an important role [2–4]. IBD manifests during childhood or adolescence in at least 20% of patients, often alternating between active and quiescent states.
Crohn's Disease and Gynecologic Manifestations in Young Women
2016, Journal of Pediatric and Adolescent GynecologyCitation Excerpt :When Crohn's disease appears after puberty begins, menstrual irregularity or heavy bleeding might be the primary presenting gynecological complaint, as was seen in our series. Little is understood about specific reasons that Crohn's might result in delayed puberty; however, theories suggest that chronic inflammation results in decreased absorptive ability of the intestine, resulting in poor weight gain and poor nutrition.14–16 One patient in our series maintained a diagnosis of Crohn's, but there was concern that her presenting symptoms could have mimicked hidradenitis suppurativa.
Mesalamine-induced myopericarditis in a paediatric patient with Crohn's disease
2015, Cardiology in the YoungChronic Mucosal Inflammation in Pediatric Intestinal Failure Patients - A Unique Phenomenon
2023, Journal of Pediatric Gastroenterology and Nutrition
Funded by: NIH, Grant number(s): 5K08DK089076; R21DK084554.